The cyclic structure of ADTC5 (Ac-CDTPPVC-NH2) peptide is known to have the ability to modulate homodimer E-cadherin interactions to form junction at the intercellular junction. Its function to inhibit E-cadherin interaction has become important to increase paracellular porosity in delivering drug molecules to the target cell. There are two types of ADTC5 state: opened-cyclic state (OCS) and closed-cyclic state (CCS). OCS of ADTC5 is affected by distance constraints, and CCS is formed by disulfide bond from terminal cysteines through force restraint. The purpose of this research is to determine the inhibition activity of ADTC5 peptide upon E-cadherin. Here we used molecular docking, and molecular dynamics approaches. The PyMOL program was generated by the structure of ADTC5 peptide. GROMACS v4.5.5 was utilized to simulate molecular dynamics. The ADTC5 peptide molecule was placed optimum in aqueous or polar condition at physiological pH. Furthermore, ADTC5 was docked with EC1-EC2 coupled domain of E-cadherin using AutoDock 4.2 and refined using molecular dynamic (MD). The result showed that CCS ADTC5 peptide has a stronger affinity and more stable interaction with EC1-EC2 coupled domain than the OCS one.
INTRODUCTION
Delivering drugs into the brain tissue is blocked by the presence of biological barricades, called the bloodbrain barrier (BBB) in the paracellular pathway [1, 2] . The paracellular pathway consists of proteins barrier at the zonula occludens (tight junctions), zonula adherens, and desmosomes (gap junctions) [3] . These proteins selectively allow the molecules with a diameter only below 11 Å and the molecular weight below 500 Dalton [4] which can pass through the paracellular pathway [5] .
The porosity of paracellular pathway can be adjusted by modulating homodimer E-cadherin interaction in the zonula adherens area at BBB [3] . The ADTC5 peptide is derived from the bulge region on the EC1 domain. This peptide has the biological activity to enhance the porosity of paracellular pathway [6] . The ADTC5 peptide has the ability to modify the BBB in the delivery of marker molecules such as, 14C-mannitol, gadolinium -diethylenetriaminepentacetate (Gd-DTPA)] to the brain over the paracellular pathways of the BBB. In vitro studies indicated that the ADTC5 had the best profile to inhibit junction resealing in Madin-Darby canine kidney cell monolayers. Furthermore, the ADTC5 peptide could increase in vivo delivery of Gd-DTPA to the brain of Balb/c mice when administered intravenously. Therefore, the ADTC5 has potential to improve delivery of diagnostic and therapeutic agents to the brain [7] .
According to the previous studies, the increasing porosity by the ADTC5 peptides predicted by forming a complex with five repeated extracellular domains (EC1, EC2, EC3, EC4, EC5) of E-cadherin [8, 9] . The study of interaction between peptide ADTC5 with Ecadherin can determine this complex formation. Knowledge of the molecular interactions will provide an understanding of the structure and eventually will be able to predict the function and properties of biomole- [10] . Moreover, study the chemical structure modifications of peptide molecule can be done to increase its biological activity. This peptide structure involve linear and cyclic forms, S--S distance from start-end terminus amino acid on each Cysteine, and force restraint. They will affect to change ADTC5 structure conformation which causes the changes of binding site location upon EC1-EC2 coupled domain. Meanwhile, an understanding of non-covalent bonds is required to learn the most favorable molecular interaction [11] .
In this work, we mainly focused on the chemical stability features which can differentiate the CCS from OCS form of the ADTC5 peptide. Moreover, we focused on the description of CCS and OCS molecules in the microscopic behavior of physical systems, such as solvation system using ion and water molecules, minimization energy, constrained and unconstrained systems. The aim of this research is to determine the ADTC5 stability and binding affinity of the ADTC5 peptide with E-cadherin's EC1-EC2 coupled domain.
The hypothesis feature was generated and performed as comparison between OCS and CCS models of the ADTC5. In this research, protein target of EC1-EC2 coupled domain was used to find the best binding mode feature of OCS and CCS. To evaluate their stability and interactions, computational aided-molecular dynamics simulations were carried out to generate 3D structures of OCS and CCS of the ADTC5 peptides. Molecular docking method was utilized to determine the interaction between OCS and CCS of the ADTC5 with EC1-EC2 coupled domain of E-cadherin protein.
MATERIALS AND METHODS

Protein and ligand preparation
The EC1-EC2 coupled domain of E-cadherin structure was retrieved from Protein Data Bank (PDB ID No. 2O72). While the PyMOL program was used to generate the structure of the ADTC5 peptide. Furthermore, this peptide molecule was simulated by molecular dynamics on GROMACS v4.5.5 [12] [13] [14] [15] . Therefore, molecular dynamics was used to obtain the optimized structure in a different fashion, OCS, and CCS of ADTC5 peptide. In preparation of ADTC5 states, sulphuric atoms within Cys1 and Cys6 residues consist of S14 and S95, respectively, and these were arranged in several different force restraints and distance constraints as shown in Table 1 .
Molecular dynamics of the ADTC5 peptide with EC1-EC2 domain of E-cadherin Molecular dynamics were conducted in three steps: (1) System preparation. This aims is to prepare ADTC5 structure and solvation system using energy minimization and position restraint, respectively. This solvation system uses a simple cubical periodic box (the dimensions of the box based upon setting the box edge approximately 1.0 nm from the molecule periphery), TIP3P (Transferable Intermolecular Potential 3-Point) water as a solvent, with ionic concentration is 0.15 M. The total number of water and ions in each simulation system are presented in Table 2 .
Trajectory generation was conducted with 120 ns (120,000 ps) running time. Analyzing trajectory by using total energy and RMSD (Root Mean Square Deviation) of a Cα atom in every second ps [11] . The widely used CHARMM27 force field was implemented in the GROMACS simulation package [16] . The Berendsen weak-coupling algorithm was used in MD simulation which is extremely efficient to minimize the error in the ensemble scales during heating or equilibrium for relaxing the system to the targeted temperature [17] . The total number of atoms present in each simulation system and the size of the Periodic Boundary Cell (PBC) were specified in Table 2 and 3. Energy minimization was given after ions addition during MD simulation. It aims to decrease the excessive forces on peptide systems, such as dihedral tension and tight non-binding contact. These appear due to the addition of water molecules and ions in the simulation box, thus cause overlapping within some water molecules and ions, and it might produce high repulsion energy due to unstable interactions.
Molecular docking of the ADTC5 peptide with EC1-EC2 domain of E-cadherin Molecular docking was run by using Autodock v.4.2 [18, 19] that involves two main parameters: Autogrid and Autodock. Autogrid is a grid box placed at: (1) Ala43, Asp44, Thr45 residues of the EC1 domain with all CCS variations (B1, B2, B3) as depicted at Figure 1 and 2. The entire surface of EC1-EC2 coupled domain, using 11 boxes with one type of CCS (B1). The size of the box is 50 × 50 × 50 (125,000 grid points) with grid spacing set at 0.375 Å (Figure 2 ). For all working types, the populations towards the genetic algorithm (GA) was 150, a maximum number of evals was 5 × 10 6 , a maximum number of generations was 27 × 10 3 , and the number of genetic algorithms (GA) was 150.
Autodock involved two stages: sampling and scoring which used Lamarckian genetic algorithm and Opened-cyclic state, OCS and b) Closed-cyclic state, CCS scoring, respectively. All default parameters were used by Autodock program. All the hydrogen added to the polar atoms on the peptides as the ligands and EC1-EC2 coupled domain as the receptor. The charge type used was Gasteiger. After running Autodock, the data was grouped into one population based on similarity of RMSD < 2Å, to get the best binding mode [20] . The active site locations of EC1-EC2 macromolecules were determined by lower energy optimization, hydrogen bonds, van der Waals forces, and hydrophobic interaction analysis.
RESULTS AND DISCUSSION
The 3D structures of the ADTC5 peptide were successfully generated by Pymol program which first built structure as OCS with different energy optimization based on modified OCS arrangements (Table 4) . To obtain its cyclic conformation, the molecular dynamics simulation was conducted to find the best-optimized structure of CCS which mimics to native form (Table  5) .
Molecular dynamics simulation at 120 ns (120,000 ps) was run to obtain the optimized OCS and CCS forms. Based on OCS result, variations of molecular dynamics simulation were conducted by two different rearrangement conditions of S14-S95 atom interactions: distance constraint and force restraint. By arranging S14-S95 distances, it showed that the longer distance A5 and shorter distance (A1, A4, A7) of S14---S95 resulted from the different energy optimizations due to rearranged-force constraints. The region of the ADTC5 peptide was restrained during minimization is atom S14 from the start-terminus amino acid of Cysteine and atom S95 from end-terminus of Cysteine. It was assumed that the closer S14---S95 distance would give more stable OCS form based on the energy optimizations. Thus, A6 A4 showed the lowest energy optimization compared to others -60,622 kJ/mol). However, the RMSD values from all OCS forms are still over 2 Å. Therefore, these OCS forms are still unstable and it suggests that the presence of other non-covalent interactions are needed to stabilize these structures, such as the amino acid side-chain interactions between the EC1-EC2 coupled domain with the ADTC5 peptide.
The A4 structure of OCS form was selected for fur further analysis. It did not form the cyclization. Therefore, the sulfide bond addition to S14 and S95 atoms should be arranged manually. Moreover, by retaining force restraint of A4 structure of OCS form at 12,000 kJ.mol -1 .nm -2 upon both atoms, it showed that A4 structure has the best OCS form with S14---S95 distance at 3.731 Å through molecular dynamics simulation ( Figure  4a) .
The CCS form with molecular dynamics simulation showed that in giving two different force restraint (4,000 and 12,000 kJ.mol -1 .nm -2 ) has resulted in similar energy optimization from B1, B2 and B3 forms (-47,044, -47,137 and -47,095 kJ/mol, respectively) as shown in Table 5 . The OCS form of the ADTC5 peptide has a rigid cyclic structure (Figure 4b ), which does not cause a change in molecular dynamics simulation. To mimic the native peptide structure of the ADTC5 peptide, CCS structure was generated. According to the average energy optimization and S14---S95 distance arrangements, it showed that CCS structure has higher energy optimization than OCS. Thus, CCS conformation is more favorable compared to OCS conformation.
Also, to obtain the lowest energy optimization, B2 of CCS form has been chosen due to it has the most stable conformation (-47,137 kJ/mol) compared to A4 of OCS form (Figure 3) . The low RMSD value has shown B2 structure is stable in molecular dynamics simulation. Thus, CCS is very stable from the initial to the final molecular dynamics process (RMSD ± 0.05 nm), while OCS is unstable (RMSD ± 0.15 nm). Moreover, CCS structures were further investigated in the way how they bind to EC1-EC2 coupled domain.
Molecular docking peptide ADTC5 with EC1-EC2 coupled domain CCS form of the ADTC5 peptide was predicted has the highest similarity with ADTC5 native structure. Thus, the interaction can represent a cyclic ADTC5 native interaction. Molecular dynamics results provide three conformations (B1, B2, and B3) in different energy optimizations. Furthermore, three CCS forms were docked with EC1-EC2 coupled domain.
In molecular docking, the best binding mode depends on: (1) the lowest affinity energy between ligand and protein, which is obtained from B1 binding mode (affinity energy -21,686 kJ/mol); (2) The highest amount of stable structures in a population, which is obtained from B1 binding mode (population of 81 structures); and (3) Validation of re-docking methods, characterized by comparing RMSD < 2 Å [21] [22] [23] , obtained from B1 binding mode (re-docking up to 76%, better than B2 and B3). The most common parameters used in molecular docking is RMSD value with the ADTC5 peptide with the lowest affinity energy.
The ADTC5 interaction with the EC1-EC2 involves (Table 6 ). Meanwhile, the best docking result of B1 was refined using Molecular Dynamics (data not shown).
Prediction inhibition of interactions EC1-EC2------EC1-EC2 with ADTC5 peptide
Five repeated extracellular domains (EC1-E2-E3-E4-EC5) of E-cadherin homophilic can interact with other E-cadherin to form cis-and trans-dimer. In the paracellular pathway, E-cadherin interaction forms junction is trans-dimer interaction with other E-cadherin. Some studies showed that the interaction could involve the other domains. These interactions are formed in two ways: (1) the interaction of groove region from EC1a domain of E-cadherin to the other EC1b domain of Ecadherin in the bulge region [6] and (2) interaction from adhesion hands that will bind to the binding pocket [24] .
Molecular docking study of the ADTC5 peptide showed that the ADTC5 inhibition upon trans-dimer interaction between EC1-EC2 extensively involved several types of chemical interactions, such as: (1) Van der Waals interaction with Ala43, Phe35 and Arg55 Asp44 and Val48 residues in the bulge region of EC1 domain and inhibits this bulge region to interact with grooves region. Also, hydrophobic interaction with Glu54, Ile52, Ile53, Tyr36, Ile38, Ser37, Val 81 and hydrogen bond with Ala43 which is between the bulge-groove regions from the EC1 domain of E-cadherin will help to inhibit interactions trans dimer in the EC1 domain. (2) Van der Waals interactions with Ile4, Lys25, Asn27 and Gln23 residues on adhesion arm region from EC1 domain of E-cadherin, as well as hydrophobic interactions with Trp2, Val3,Met92, Ile24, Ser26 on binding pocket region from EC1 domain of E-cadherin, thus the interaction at binding pocket-adhesion arm region on EC1 domain of E-cadherin will be hindered by ADTC5 peptide and hydrogen bonds are Gln23 and Trp2; (3) hydrophobic interactions of Asp1, Trp2 and Pro3 residues; and (4) hydrogen bond interactions with Val3 in the Adhesive Arm of EC1 ( Figure 5 ). These three binding sites would inhibit the formation of trans-dimer between EC1-EC2 coupled domains on the adjacent cells. Thus the interaction on junction will be weaker, and the paracellular pathways will be widely opened.
In finding the ΔG value, the ADTC5 peptide in three CCS forms (B1, B2, B3) have been re-docked over than 1000 scoring iterations. ΔG value for B1 is within the range -12.93 to -16.95 kJ/mol; B2 is within the range -11.13 to -16.28 kJ/mol; and B3 is within the range -10.46 to -17.45 kJ/mol. On the other hand, the affinity of the ADTC5 peptide in inhibiting trans-dimer EC1-EC2 also can be determined through inhibition constant values (Ki). The Ki value of B3 is found having the strongest affinity (0.88 mM at pose 124) compared to B1 and B2 (Table 6 ). Meanwhile, Ki value was found using formula ΔG = RT ln Ki (where ΔG is Gibbs free energy (kJ.mol -1 ), R is ideal gas constant (8.314 J.mol -1 .K -1 ), and Ki is inhibition constant (mM)).
The ADTC5 peptide was re-oriented towards the surface when it interacts with EC1-EC2 coupled domain. This phenomenon can be seen by a B1 form of the ADTC5 that has the best optimization of energy when the molecular dynamics does not have a good interaction energy. It is claimed that structure with the best optimization does not have to produce the best interaction energy due to a re-orientation towards the target. The best affinity energy is a B3 form (affinity energy is -17.45 kJ/mol) of the ADTC5 peptide analyzed with molecular docking at the entire surface of the EC1-EC2 coupled domain ( Table 5 ). The result obtained that the entire interaction energy is spontaneous by giving negative value on the affinity energy. Moreover, the presence hydrogen bonds, van der Waals forces, and hydrophobic interactions to stabilize the ADTC5 peptide interaction with the EC1-EC2 domain [25] . The affinity property of the ADTC5 peptide will affect the drug delivery that across the paracellular pathways. In delivering the drug to body and brain cells, the ADTC5 cyclic peptide will increase the porosity of paracellular pathway and allow the drug molecules to pass through it. However, the modulating of the paracellular pathway will need Ki value less than 100 µM [10] . It will increase the porosity of ADCT5 peptide and allow the drug goes to the target cell and through the paracellular pathway. This study will be very useful in designing more potential cyclic peptides derived from E-cadherin protein.
CONCLUSION
Our study showed that CCS of the ADTC5 peptide has more stable interactions with EC1 domain than the OCS one. Pre-experiment proved that ADTC5 which mimics to the native structure is in cyclic conformation, with optimization energy at -47,137 kJ/mol and it is very stable from initial to final molecular dynamics simulation process (RMSD ratio ± 0.5Å). Molecular docking study between the ADTC5 with EC1-EC2 coupled domain showed the best binding mode to EC1 (Box D), EC1 (Box E), and EC2 (Box I) with the affinity energy at -21.686 kJ/mol, -20.215 kJ/mol, and -12.726 kJ/ mol, respectively. 
